Investing Ideas
/
Chinese Pharmaceuticals & Biotech Your first investment

Chinese Pharmaceuticals & Biotech Your first investment

Results

0 new

Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

14 companies

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥123.9b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

600436

CN¥205.42

-1.6%

-10.8%

Yunnan Baiyao GroupLtd

Market Cap: CN¥101.0b

Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.

000538

CN¥56.58

-0.3%

4.9%

Sichuan Kelun Pharmaceutical

Market Cap: CN¥62.6b

Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.

002422

CN¥39.35

12.4%

17.6%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥53.9b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥41.99

0.5%

-10.2%

Beijing Tongrentang

Market Cap: CN¥51.6b

Engages in the scientific research, production, distribution, and sale of Chinese medicines in China.

600085

CN¥37.59

-0.2%

-17.4%

Changchun High-Tech Industry (Group)

Market Cap: CN¥41.3b

Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.

000661

CN¥102.39

2.6%

-8.7%

Livzon Pharmaceutical Group

Market Cap: CN¥29.4b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.

000513

CN¥36.65

3.7%

-5.2%

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥22.5b

Engages in production, marketing, and services related to central nervous system drugs in China.

002262

CN¥22.15

2.3%

-3.7%

Apeloa PharmaceuticalLtd

Market Cap: CN¥16.0b

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥13.85

-1.4%

-7.4%

Zhejiang Medicine

Market Cap: CN¥13.2b

Manufactures and sells life nutrition and pharmaceutical products in China.

600216

CN¥13.76

0.8%

35.6%

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥13.1b

Operates as contract development and manufacturing organization company in China and internationally.

603456

CN¥14.69

3.2%

-3.5%

KPC PharmaceuticalsInc

Market Cap: CN¥12.2b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.

600422

CN¥16.07

1.8%

-28.9%

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥11.2b

Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.

300119

CN¥24.48

1.6%

53.2%

Zhejiang Jingxin Pharmaceutical

Market Cap: CN¥11.1b

Zhejiang Jingxin Pharmaceutical Co., Ltd.

002020

CN¥13.44

0.4%

19.5%